Dr. Jeanne M. Meis is currently a Professor of Pathology and the Section Head of Bone and Soft Tissue Pathology at the University of Texas MD Anderson Cancer Center in Houston, TX, USA. She is internationally recognized as an expert diagnostician and for her research contributions to sarcoma pathology diagnosis and treatment. She has previously been the Chair of the Department of Soft Tissue Pathology at the Armed Forces Institute of Pathology in Washington, DC, USA; Professor of Pathology at Gothenburg University Hospital in Gothenburg, Sweden; and Professor of Pathology at The Medical School, University of Birmingham, Birmingham, United Kingdom as well as a Consultant Histopathologist at the Royal Orthopaedic Hosptial NHS Foundation Trust in the UK. She is a reviewer for several journals and a member of many prestigious societies including the Arthur Purdy Stout Society and the International Skeletal Society. She has nearly 200 publications including peer-reviewed articles, book chapters and abstracts and has played a major contributing role in all of her publications. Some of her most notable contributions have been the description of new or under-recognized entities and delineation of prognostic factors, including chondroid lipoma, myolipoma of soft tissue, juxta-articular myxoma, proliferative fasciitis and myositis of childhood, inflammatory fibrosarcoma (malignant IMT), sclerosing epithelioid fibrosarcoma, cellular variant of fetal rhadomyoma, angiosarcoma in MPNST, epithelioid schwannoma, (acral) myxoinflammatory fibroblastic sarcoma, criteria for malignancy in granular cell tumors of soft tissue, initial expression of cKIT / CD117 in GIST, extraskeletal myxoid chondrosarcoma (EMC) of bone, synovial sarcoma of peripheral nerves, new translocations in angiomatoid fibrous histiocytoma and EMC, and the most authoritative publication to date on EMC. She has also given innumberable courses and presentations at international, national and local venues.